Surgery Partners, Inc.SGRYNASDAQ
LOADING
|||
Switch Symbol:
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +14.29% | +17.54% | +8.17% | +8.41% | +6.63% |
| Gross Profit Growth | +7.06% | +20.66% | +4.25% | +9.15% | +10.03% |
| EBITDA Growth | -0.36% | +21.51% | -10.48% | +27.09% | +264.90% |
| Operating Income Growth | -26.27% | +25.35% | -18.55% | +31.72% | +73.56% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | -186.21% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | -186.21% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.34% | +0.35% | +0.50% | +0.67% | +0.60% |
| Weighted Average Shares Diluted Growth | +0.34% | +0.35% | +0.50% | +0.67% | +0.60% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -37.67% | +77.96% | -85.26% | -1.81% | +28.22% |
| Free Cash Flow Growth | -47.49% | +108.18% | -184.77% | +3.58% | +41.78% |
| Receivables Growth | +17.31% | +16.66% | +15.44% | +7.59% | +6.70% |
| Inventory Growth | +18.16% | +17.55% | +14.42% | +7.91% | +12.56% |
| Asset Growth | +11.13% | +14.74% | +13.96% | +6.23% | +5.47% |
| Book Value per Share Growth | -5.71% | -10.25% | -11.97% | -11.05% | -9.35% |
| Debt Growth | +17.22% | +20.96% | +22.66% | +13.11% | +10.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -20.65% | +72.25% | +8.43% | -10.42% | +1008.90% |